phentermine and orlistat

phentermine has been researched along with orlistat in 51 studies

Research

Studies (51)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (5.88)	18.2507
2000's	10 (19.61)	29.6817
2010's	26 (50.98)	24.3611
2020's	12 (23.53)	2.80

Authors

Authors	Studies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Borrell, L; Foreyt, JP; Haddock, CK; Poston, WS	1
Apovian, CM	1
Birkeland, KI; Tonstad, S	1
Ballmer, PE; Imoberdorf, R	1
Hanif, MW; Kumar, S	1
Gura, T	1
Li, Z; Maggard, M; Maglione, M; Mojica, WA; Morton, SC; Shekelle, PG; Shugarman, L; Solomon, V; Suttorp, M; Tu, W	1
Arterburn, D	2
Arterburn, D; DeLaet, D; Flum, D	1
Dixon, JB	1
Pi-Sunyer, FX	1
Kaplan, LM	1
Carter, R; Mouralidarane, A; Oben, J; Ray, S; Soeda, J	1
Charakida, M; Finer, N; Tousoulis, D	1
Block, JP; Brennan, TA; Carpenter, DP; Choudhry, NK; Fischer, MA; Matlin, OS; Shrank, WH; Tong, AY	1
Boulghassoul-Pietrzykowska, N; Franceschelli, J; Still, C	1
Baretić, M	1
le Roux, CW; Miras, AD	1
Nakazato, M; Ueno, H	1
Elliott, J; Gourash, W; Kalarchian, M; Turk, M	1
Bray, GA	1
Ryan, DH	1
Dahiya, N; Kakkar, AK	1
Bragg, R; Crannage, E	1
Berghold, A; Horvath, K; Jeitler, K; Meschik, J; Posch, N; Semlitsch, T; Siebenhofer, A	1
Camilleri, M; Chandar, AK; Dulai, PS; Khera, R; Loomba, R; Murad, MH; Prokop, LJ; Singh, S; Wang, Z	1
Braverman-Panza, J; Fujioka, K	1
Aronne, LJ; Igel, LI; Kumar, RB; Saunders, KH	1
Curry, SA	1
Dixon, J; Lee, PC	1
Golden, A	1
Grabarczyk, TR	1
Bersoux, S; Byun, TH; Chaliki, SS; Poole, KG	1
Aronne, LJ; Chukir, T; Saunders, KH; Shukla, AP	1
Andrew, CA; Aronne, LJ; Saunders, KH; Shukla, AP	1
Brown, SA; Izzy, M; Watt, KD	1
Kim, S; Son, JW	1
Lee, SY; Tak, YJ	1
Berghold, A; Horvath, K; Jeitler, K; Krenn, C; Semlitsch, T; Siebenhofer, A; Winterholer, S	1
Ahmad, NN; Kan, H; Kennedy-Martin, T; Poon, JL; Robinson, S	1
Ard, JD; Cohen, JB; Egan, BM; Hall, JE; Hall, ME; Lavie, CJ; Ma, J; Ndumele, CE; Schauer, PR; Shimbo, D	1
Kaur, N; Levin, A; Mainoo, NK; Perez, A	1
Choi, MH; Kwon, GE; Kwon, YJ; Lee, HS; Lee, JW	1
Germanidis, GS; Giouleme, O; Goulas, A; Goulis, DG; Polyzos, SA	1
Hill, A; Levi, J; Venter, F; Wang, J	1
Amatuzio, A; Baranello, S; Buondonno, A; Corvinelli, M; De Stefano, F; Di Cienzo, G; Nazzaro, P; Principe, F; Trucillo, P; Vitagliano, C	1
Mital, S; Nguyen, HV	1

Reviews

38 review(s) available for phentermine and orlistat

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Challenges in obesity management. Southern medical journal, 1998, Volume: 91, Issue:8 Topics: 1-Naphthylamine; Adrenergic beta-Agonists; Appetite Depressants; Behavior Therapy; Caffeine; Cyclobutanes; Diethylpropion; Ephedrine; Fenfluramine; Fluoxetine; Humans; Lactones; Leptin; Lipase; Obesity; Orlistat; Phentermine; Proteins; Sertraline	1998
The use of pharmacologic agents in the treatment of the obese patient. The Journal of the American Osteopathic Association, 1999, Volume: 99, Issue:10 Su Pt 2 Topics: Anti-Obesity Agents; Body Mass Index; Cyclobutanes; Female; Follow-Up Studies; Humans; Lactones; Male; Obesity; Orlistat; Phentermine; Weight Loss	1999
[The obesity epidemics--do diet pills have a place in the treatment?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2000, Jun-30, Volume: 120, Issue:17 Topics: Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Fenfluramine; Humans; Lactones; Leptin; Obesity; Obesity, Morbid; Orlistat; Phentermine; Selective Serotonin Reuptake Inhibitors; Weight Loss	2000
[Obesity: principles of drug therapy]. Therapeutische Umschau. Revue therapeutique, 2000, Volume: 57, Issue:8 Topics: Aminorex; Anti-Obesity Agents; Appetite Depressants; Chronic Disease; Combined Modality Therapy; Cyclobutanes; Dexfenfluramine; Diet, Reducing; Drug and Narcotic Control; Germany; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Lactones; Obesity; Orlistat; Phentermine	2000
Pharmacological management of obesity. Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:12 Topics: Anti-Obesity Agents; Appetite Depressants; Clinical Trials as Topic; Cyclobutanes; Humans; Lactones; Methylcellulose; Obesity; Orlistat; Phentermine	2002
Pharmacological and surgical treatment of obesity. Evidence report/technology assessment (Summary), 2004, Issue:103 Topics: Adult; Appetite Depressants; Bupropion; Cyclobutanes; Diethylpropion; Fluoxetine; Fructose; Gastric Bypass; Gastroplasty; Humans; Lactones; Lipase; Obesity; Orlistat; Phentermine; Topiramate	2004
Obesity. Clinical evidence, 2003, Issue:10 Topics: Adult; Appetite Depressants; Cyclobutanes; Diethylpropion; Fluoxetine; Humans; Lactones; Mazindol; Obesity; Orlistat; Phentermine; Phenylpropanolamine	2003
Obesity. Clinical evidence, 2004, Issue:11 Topics: Adult; Appetite Depressants; Cyclobutanes; Diethylpropion; Fluoxetine; Humans; Lactones; Mazindol; Obesity; Orlistat; Phentermine; Phenylpropanolamine; Selective Serotonin Reuptake Inhibitors	2004
Obesity. Clinical evidence, 2005, Issue:13 Topics: Adult; Appetite Depressants; Cyclobutanes; Diethylpropion; Fluoxetine; Gastric Bypass; Gastroplasty; Humans; Lactones; Mazindol; Obesity; Orlistat; Phentermine	2005
Weight loss medications--where do they fit in? Australian family physician, 2006, Volume: 35, Issue:8 Topics: Anti-Obesity Agents; Chronic Disease; Cyclobutanes; Diethylpropion; Humans; Lactones; Obesity; Orlistat; Phentermine; Weight Loss	2006
Use of lifestyle changes treatment plans and drug therapy in controlling cardiovascular and metabolic risk factors. Obesity (Silver Spring, Md.), 2006, Volume: 14 Suppl 3 Topics: Caloric Restriction; Cardiovascular Diseases; Cyclobutanes; Diabetes Mellitus; Diet; Diet, Fat-Restricted; Diet, Mediterranean; Exercise; Feeding Behavior; Food, Formulated; Humans; Lactones; Metabolic Syndrome; Obesity; Orlistat; Phentermine; Prediabetic State; Risk Reduction Behavior; Weight Loss	2006
Pharmacologic therapies for obesity. Gastroenterology clinics of North America, 2010, Volume: 39, Issue:1 Topics: Anti-Obesity Agents; Appetite Depressants; Bariatric Surgery; Benzazepines; Bupropion; Cyclobutanes; Ephedrine; Fenfluramine; Humans; Lactones; Naltrexone; Obesity; Orlistat; Phentermine; Weight Gain; Weight Loss	2010
Recent advancements in drug treatment of obesity. Clinical medicine (London, England), 2012, Volume: 12, Issue:5 Topics: Anti-Obesity Agents; Benzazepines; Benzoxazines; Bupropion; Clinical Trials as Topic; Drug Combinations; Fructose; Glucagon-Like Peptide 1; Humans; Lactones; Life Style; Liraglutide; Naltrexone; Obesity; Orlistat; Phentermine; Topiramate; Weight Loss	2012
Drug treatment of obesity in the cardiovascular patient. Current opinion in cardiology, 2013, Volume: 28, Issue:5 Topics: Anti-Obesity Agents; Benzazepines; Cardiovascular Diseases; Fructose; Humans; Lactones; Obesity; Orlistat; Phentermine; Topiramate	2013
New medications for obesity management: changing the landscape of obesity treatment. Current opinion in endocrinology, diabetes, and obesity, 2013, Volume: 20, Issue:5 Topics: Anti-Obesity Agents; Delayed-Action Preparations; Drugs, Investigational; Fructose; Humans; Lactones; Obesity; Orlistat; Phentermine; Topiramate; Weight Reduction Programs	2013
Obesity drug therapy. Minerva endocrinologica, 2013, Volume: 38, Issue:3 Topics: Anti-Obesity Agents; Appetite; Combined Modality Therapy; Comorbidity; Cost-Benefit Analysis; Cyclobutanes; Diabetes Mellitus, Type 2; Diet, Diabetic; Drug Combinations; Exercise Therapy; Fructose; Gastrointestinal Hormones; Humans; Incretins; Insulin; Insulin Secretion; Intestines; Lactones; Leptin; Life Style; Models, Biological; Neuropeptides; Obesity; Orlistat; Phentermine; Phytotherapy; Piperidines; Plant Preparations; Pyrazoles; Rimonabant; Topiramate	2013
Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery? International journal of obesity (2005), 2014, Volume: 38, Issue:3 Topics: Anti-Obesity Agents; Bariatric Surgery; Benzazepines; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Exercise; Feeding Behavior; Female; Fructose; Glucagon-Like Peptide-1 Receptor; Glucosides; Glycated Hemoglobin; Homeostasis; Humans; Islet Amyloid Polypeptide; Lactones; Male; Minimally Invasive Surgical Procedures; Obesity, Morbid; Orlistat; Phentermine; Receptors, Glucagon; Topiramate; Treatment Outcome; Weight Loss	2014
[Cutting-edge of medicine; the prospects of novel anti-obesity drugs]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2014, Mar-10, Volume: 103, Issue:3 Topics: Anti-Obesity Agents; Appetite; Appetite Depressants; Benzazepines; Benzoxazines; Bupropion; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Discovery; Energy Metabolism; Enzyme Inhibitors; Fructose; Glucagon-Like Peptide 1; Humans; Hypothalamus; Lactones; Lipase; Liraglutide; Metabolic Syndrome; Naltrexone; Obesity; Orlistat; Phentermine; Topiramate	2014
Lifestyle management for enhancing outcomes after bariatric surgery. Current diabetes reports, 2014, Volume: 14, Issue:10 Topics: Appetite Depressants; Bariatric Surgery; Behavior Therapy; Comorbidity; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Directive Counseling; Exercise; Feeding Behavior; Gastric Bypass; Humans; Lactones; Obesity, Morbid; Orlistat; Patient Compliance; Phentermine; Pilot Projects; Postoperative Period; Randomized Controlled Trials as Topic; Weight Loss	2014
Medical treatment of obesity: the past, the present and the future. Best practice & research. Clinical gastroenterology, 2014, Volume: 28, Issue:4 Topics: Anti-Obesity Agents; Benzazepines; Drug Therapy, Combination; Fructose; Humans; Lactones; Obesity; Orlistat; Phentermine; Topiramate; Weight Loss	2014
The pharmacological and surgical management of adults with obesity. The Journal of family practice, 2014, Volume: 63, Issue:7 Suppl Topics: Adult; Aged; Anti-Obesity Agents; Appetite Depressants; Bariatric Surgery; Benzazepines; Fructose; Humans; Lactones; Middle Aged; Obesity; Orlistat; Phentermine; Topiramate	2014
Drug treatment of obesity: current status and future prospects. European journal of internal medicine, 2015, Volume: 26, Issue:2 Topics: Anti-Obesity Agents; Benzazepines; Bupropion; Drug Combinations; Drug Therapy, Combination; Fructose; Humans; Lactones; Naltrexone; Obesity; Orlistat; Phentermine; Topiramate	2015
Long-term effects of weight-reducing drugs in people with hypertension. The Cochrane database of systematic reviews, 2016, Mar-02, Volume: 3 Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Blood Pressure; Cyclobutanes; Diet, Reducing; Female; Fructose; Humans; Hypertension; Lactones; Male; Middle Aged; Orlistat; Phentermine; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Safety-Based Drug Withdrawals; Time; Topiramate; Weight Loss	2016
Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. JAMA, 2016, Jun-14, Volume: 315, Issue:22 Topics: Anti-Obesity Agents; Bayes Theorem; Benzazepines; Drug Combinations; Female; Fructose; Humans; Lactones; Liraglutide; Male; Middle Aged; Naltrexone; Obesity; Orlistat; Phentermine; Randomized Controlled Trials as Topic; Topiramate; Weight Loss	2016
Practical Use of Pharmacotherapy for Obesity. Gastroenterology, 2017, Volume: 152, Issue:7 Topics: Androgens; Anti-Obesity Agents; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Appetite Depressants; Benzazepines; Bupropion; Drug Combinations; Fructose; Humans; Hypoglycemic Agents; Hypogonadism; Lactones; Liraglutide; Naltrexone; Obesity; Orlistat; Phentermine; Testosterone; Topiramate; Weight Gain	2017
Current pharmacotherapies for obesity: A practical perspective. Journal of the American Association of Nurse Practitioners, 2017, Volume: 29, Issue:S1 Topics: Adult; Anti-Obesity Agents; Benzazepines; Female; Humans; Lactones; Liraglutide; Middle Aged; Naltrexone; Obesity; Orlistat; Phentermine; Risk Reduction Behavior; United States	2017
Pharmacotherapy for obesity: What you need to know. Cleveland Clinic journal of medicine, 2017, Volume: 84, Issue:12 Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Benzazepines; Bupropion; Drug Combinations; Humans; Lactones; Liraglutide; Naltrexone; Obesity; Orlistat; Phentermine	2017
Pharmacotherapy for obesity in individuals with type 2 diabetes. Expert opinion on pharmacotherapy, 2018, Volume: 19, Issue:3 Topics: Anti-Obesity Agents; Benzazepines; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Compounding; Humans; Lactones; Liraglutide; Obesity; Orlistat; Phentermine; Weight Loss	2018
Treating obesity in patients with cardiovascular disease: the pharmacotherapeutic options. Expert opinion on pharmacotherapy, 2019, Volume: 20, Issue:5 Topics: Anti-Obesity Agents; Benzazepines; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Liraglutide; Obesity; Orlistat; Phentermine; Weight Loss	2019
Pharmacotherapy for Weight Loss in Cirrhosis and Liver Transplantation: Translating the Data and Underused Potential. Hepatology (Baltimore, Md.), 2021, Volume: 73, Issue:5 Topics: Anti-Obesity Agents; Bupropion; Drug Therapy, Combination; Humans; Liraglutide; Liver Cirrhosis; Liver Transplantation; Naltrexone; Obesity; Orlistat; Phentermine; Topiramate; Translational Science, Biomedical	2021
Comprehensive Review of Current and Upcoming Anti-Obesity Drugs. Diabetes & metabolism journal, 2020, Volume: 44, Issue:6 Topics: Anti-Obesity Agents; Benzazepines; Humans; Orlistat; Phentermine; Weight Loss	2020
Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand? Current obesity reports, 2021, Volume: 10, Issue:1 Topics: Animals; Anti-Obesity Agents; Benzazepines; Bupropion; Humans; Liraglutide; Naltrexone; Obesity; Orlistat; Overweight; Phentermine; Topiramate; United States; United States Food and Drug Administration; Weight Loss	2021
Long-term effects of weight-reducing drugs in people with hypertension. The Cochrane database of systematic reviews, 2021, 01-17, Volume: 1 Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Bias; Blood Pressure; Body Weight; Bupropion; Diet, Reducing; Drug Combinations; Female; Fructose; Humans; Hypertension; Lactones; Male; Middle Aged; Naltrexone; Orlistat; Phentermine; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Safety-Based Drug Withdrawals; Time; Topiramate	2021
Clinical outcomes associated with anti-obesity medications in real-world practice: A systematic literature review. Obesity reviews : an official journal of the International Association for the Study of Obesity, 2021, Volume: 22, Issue:11 Topics: Adult; Anti-Obesity Agents; Humans; Orlistat; Phentermine; State Medicine; Weight Loss	2021
Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association. Hypertension (Dallas, Tex. : 1979), 2021, Volume: 78, Issue:5 Topics: American Heart Association; Anti-Obesity Agents; Appetite Depressants; Bariatric Surgery; Exercise; Humans; Hypertension; Obesity; Orlistat; Phentermine; United States; Weight Loss	2021
Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease. Current obesity reports, 2022, Volume: 11, Issue:3 Topics: Anti-Obesity Agents; Humans; Liraglutide; Non-alcoholic Fatty Liver Disease; Obesity; Orlistat; Phentermine; Sodium-Glucose Transporter 2 Inhibitors	2022
[Renal Damage and Obesity: a Silent Pairing]. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2023, Jun-29, Volume: 40, Issue:3 Topics: Anti-Obesity Agents; Humans; Kidney; Obesity; Orlistat; Phentermine	2023

Trials

1 trial(s) available for phentermine and orlistat

Article	Year
The Effect of Orlistat on Sterol Metabolism in Obese Patients. Frontiers in endocrinology, 2022, Volume: 13 Topics: Adult; Anti-Obesity Agents; Cholesterol; Double-Blind Method; Humans; Lactones; Lipase; Obesity; Orlistat; Overweight; Oxysterols; Phentermine; Weight Loss	2022

Other Studies

12 other study(ies) available for phentermine and orlistat

Article	Year
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Orlistat for obesity. The Medical letter on drugs and therapeutics, 1999, Jun-18, Volume: 41, Issue:1055 Topics: Anti-Obesity Agents; Appetite Depressants; Clinical Trials as Topic; Cyclobutanes; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Fees, Pharmaceutical; Humans; Intestinal Absorption; Lactones; Lipase; Obesity; Orlistat; Phentermine	1999
Obesity drug pipeline not so fat. Science (New York, N.Y.), 2003, Feb-07, Volume: 299, Issue:5608 Topics: Agouti-Related Protein; alpha-MSH; Animals; Anti-Obesity Agents; Appetite; Arcuate Nucleus of Hypothalamus; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Energy Intake; Ghrelin; Humans; Hunger; Intercellular Signaling Peptides and Proteins; Lactones; Leptin; Mice; Nerve Tissue Proteins; Neurons; Neuropeptide Y; Obesity; Orlistat; Peptide Fragments; Peptide Hormones; Peptide YY; Phentermine; Proteins; Receptors, Corticotropin; Receptors, Melanocortin; Weight Loss	2003
Time series analyses of the effect of FDA communications on use of prescription weight loss medications. Obesity (Silver Spring, Md.), 2014, Volume: 22, Issue:3 Topics: Adolescent; Adult; Aged; Anti-Obesity Agents; Appetite Depressants; Cohort Studies; Cyclobutanes; Drug Utilization; Female; Humans; Lactones; Male; Middle Aged; Obesity; Orlistat; Phentermine; United States; United States Food and Drug Administration; Weight Loss; Young Adult	2014
Review of pharmacotherapy options for the management of obesity. Journal of the American Association of Nurse Practitioners, 2016, Volume: 28, Issue:2 Topics: Benzazepines; Bupropion; Disease Management; Fructose; Humans; Lactones; Liraglutide; Naltrexone; Obesity; Orlistat; Phentermine; Topiramate; United States	2016
Answers to Clinical Questions in the Primary Care Management of People with Obesity: Pharmacologic Management. The Journal of family practice, 2016, Volume: 65, Issue:7 Suppl Topics: Anti-Obesity Agents; Benzazepines; Body Mass Index; Bupropion; Guidelines as Topic; Humans; Lactones; Life Style; Liraglutide; Naltrexone; Obesity; Orlistat; Overweight; Phentermine; Primary Health Care; Risk Factors; Treatment Outcome; Weight Loss	2016
Obesity Epidemic: Pharmaceutical Weight Loss. Rhode Island medical journal (2013), 2017, Mar-01, Volume: 100, Issue:2 Topics: Anti-Obesity Agents; Benzazepines; Body Mass Index; Bupropion; Drug Combinations; Fructose; Humans; Lactones; Liraglutide; Naltrexone; Obesity; Orlistat; Phentermine; Weight Loss	2017
Pharmacotherapy for obesity. Australian family physician, 2017, Volume: 46, Issue:7 Topics: Anti-Obesity Agents; Appetite Depressants; Body Mass Index; Drug Therapy; Drug Therapy, Combination; Fructose; Humans; Incretins; Lactones; Liraglutide; Obesity; Orlistat; Phentermine; Topiramate	2017
Observational Comparative Effectiveness of Pharmaceutical Treatments for Obesity within the Veterans Health Administration. Pharmacotherapy, 2018, Volume: 38, Issue:1 Topics: Adult; Aged; Anti-Obesity Agents; Benzazepines; Body Weight; Cohort Studies; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Obesity; Orlistat; Phentermine; Retrospective Studies; Topiramate; United States; United States Department of Veterans Affairs; Weight Loss	2018
Prevalence of Antiobesity Treatment and Weight-Inducing Antihyperglycemic Agents Among Patients With Type 2 Diabetes in the United States. Clinical therapeutics, 2022, Volume: 44, Issue:3 Topics: Adult; Anti-Obesity Agents; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Liraglutide; Nutrition Surveys; Obesity; Orlistat; Phentermine; Prevalence; Topiramate; United States; Weight Loss	2022
Estimated minimum prices and lowest available national prices for antiobesity medications: Improving affordability and access to treatment. Obesity (Silver Spring, Md.), 2023, Volume: 31, Issue:5 Topics: Anti-Obesity Agents; Bupropion; Drug Combinations; Health Care Costs; Health Services Accessibility; Liraglutide; Naltrexone; Orlistat; Phentermine; Topiramate	2023
Cost-Effectiveness of Antiobesity Drugs for Adolescents With Severe Obesity. JAMA network open, 2023, 10-02, Volume: 6, Issue:10 Topics: Adolescent; Anti-Obesity Agents; Child; Cost-Benefit Analysis; Female; Humans; Liraglutide; Male; Obesity; Obesity, Morbid; Orlistat; Phentermine; Topiramate	2023